Vandoros S and Kanavos P (2013) The generics paradox revisited: empirical evidence from regulated markets. Applied economics, 45 (22). pp. 3230-3239. ISSN 0003-6846

Kanavos P (2007) Do generics offer significant savings to the UK National Health Service? Current Medical Research and Opinion, vol. 23(1). Current medical research and opinion, 23 (1). pp. 105-116. ISSN 0300-7995

King DR and Kanavos P (2002) Encouraging the use of generic medicines: implications for transition economies. Croatian medical journal, 43 (4). pp. 462-469. ISSN 0353-9504

Competition

Kanavos, Panos and Wouters, Olivier J. (2014) Competition issues in the distribution of pharmaceuticals (French version)

For further information please contact: Olivier Wouters (o.j.wouters@lse.ac.uk), Panos Kanavos (p.g.kanavos@lse.ac.uk)

External Price Referencing (EPR)

EPR schemes can have varying impacts on short- and long-run prices, market dynamics, key stakeholders, and other relevant outcomes. This research evaluates the merits and demerits of EPR in the short- and the long-run from an efficiency, equity, and quality perspective. A theoretical and empirical analysis of the effectiveness of EPR is conducted, based on a systematic review of the literature and primary data analysis. As EPR has been most common in Europe, the study focuses on this region. A LSE discussion paper, a conference presentation, and an article in a peer-reviewed journal are forthcoming.

Kanavos P, Nicod E, Espin J and van den Aardweg S (2010) Short- and long-term effects of value-based pricing vs. external price referencing. EMiNet.

Pharmaceutical Parallel Trade

The project reviewed the legal, policy and economic debate over pharmaceutical parallel trade, including the stakeholder implications as well as the competition and welfare effects. As pharmaceutical parallel trade has been most common in the European Union, much of the research focused on this region. A chapter is forthcoming in the Elsevier Encyclopedia of Health Economics (2014).

Kanavos, Panos and Wouters, Olivier J. (2014) Pharmaceutical parallel trade: legal, policy, and economic issues In: Culyer, Anthony J., (ed.) Encyclopedia of health economics. Elsevier, San Diego, USA, 20-28. ISBN 9780123756787

Kanavos P and Vandoros S (2010) Competition in prescription drug markets: is parallel trade the answer? Managerial and decision economics, 31 (5). pp. 325-338. ISSN 0143-6570

Kanavos P and Costa-i-Font J (2005) Pharmaceutical parallel trade in Europe: stakeholders and competition effects. Economic policy, 20 (44). pp. 751-798. ISSN 0266-4658

Kanavos P and Kowal S (2008), Does pharmaceutical parallel trade serve the objectives of cost control?, EuroHealth 14:2